Pulmonary Aspects of Aging

  • Donald A. Mahler


This chapter focuses on four topics concerning respiratory function and disease in the elderly population. First, understanding the effects of aging on lung function and gas exchange provides the basis for distinguishing between age-related alterations and dysfunction. Health, at whatever age, is most often determined by the ability of an individual to perform activities of daily living, to work, and/or to participate in recreational interests. In order to achieve these objectives, the elderly person must develop and maintain a minimal level of exercise tolerance. Accordingly, the physiologic interactions affecting exercise performance in the elderly will be discussed.


Chronic Obstructive Pulmonary Disease Force Vital Capacity Pulmonary Artery Pressure Chronic Bronchitis Beclomethasone Dipropionate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wynne, J. W., 1979, Pulmonary disease in the elderly, in: Clinical Geriatrics (I. Rossman, ed.), J. B. Lippincott Co., Philadelphia.Google Scholar
  2. 2.
    Hutchinson, J., 1946, On the capacity of the lungs and on respiratory functions, with a view of establishing a precise and easy method of detecting disease by the spirometer, Med. Air Trans. (London) 29:662–289.Google Scholar
  3. 3.
    Muiesan, G., Sorbini, C. A., and Grassi, V., 1971, Respiratory function in the aged, Bull. Physiopath. Resp. 7:973–1009.Google Scholar
  4. 4.
    Morris, J. F., Kolski, A., and Johnson, L. C., 1971, Spirometric standards for healthy nonsmoking adults, Am. Rev. Respir. Dis. 103:57–67.PubMedGoogle Scholar
  5. 5.
    Cotes, J. E., Rossiter, G. E., Higgins, I. T. T., and Gilson, J. C., 1966, Average normal values for the forced expiratory volume in white Caucasian males, Br. Med. Jr. 1:1016–1019.Google Scholar
  6. 6.
    Kory, R. C., Callahan, K., Boren, H. G, and Syner, J. C., 1961, The Veterans Administration-Army cooperative in normal men, Am. J. Med. 30:243–258.PubMedGoogle Scholar
  7. 7.
    Knudson, R. J., 1981, How aging affects the normal adult lung, J. Respir. Dis. 2:74–84.Google Scholar
  8. 8.
    Knudson, R. J., Clark, D. F., Kennedy, T. C., and Knudson, D. E., 1977, Effect of aging alone on mechanical properties of the normal adult human lung, J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 43:1054–1062.Google Scholar
  9. 9.
    Turner, J. M., Mead, J., and Wohl, M. E., 1968, Elasticity of human lungs in relation to age, J. Appl. Physiol. 25:664–671.PubMedGoogle Scholar
  10. 10.
    Mellemgaard, K., 1966, Alveolar-arterial oxygen difference: Size and components in normal man. Acta Physiol. Scand. 67:10–20.PubMedGoogle Scholar
  11. 11.
    Sorbini, C. A., Grassi, V., Solinas, E., and Muiesan, G., 1968, Arterial oxygen tension in relation to age in healthy subjects, Respiration, 25:3–10.PubMedGoogle Scholar
  12. 12.
    Ricci, B., 1967, Physiological Basis of Human Performance, Lea and Febiger, Philadelphia.Google Scholar
  13. 13.
    Black, L. F. and Hyatt, R. E., 1969, Maximal respiratory pressures: Normal values and relationship to age and sex, Am. Rev. Respir. Dis. 99:696–702.PubMedGoogle Scholar
  14. 14.
    Kronenberg, R. S. and Drage, C. W., 1973, Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men, J. Clin. Invest. 52:1812–1819.PubMedGoogle Scholar
  15. 15.
    Peterson, D. D., Pack, A. I., Silage, D. A., and Fishman, A. P., 1981, Effects of aging on ventilatory and occlusion pressure responses to hypoxia and hypercapnia, Am. Rev. Respir. Dis. 124:387–391.PubMedGoogle Scholar
  16. 16.
    Gerrard, J. W., Cockcroft, D. W., Mink, J. T., Cotton, D. J., Poonawala, R., 1980, Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function, Am. Rev. Respir. Dis. 122:557–581.Google Scholar
  17. 17.
    White, J. R. and Froeb, H. F., 1982, Small-airways dysfunction in nonsmokers chronically exposed to tobacco smoke, N. Engl. J. Med. 302:720–723.Google Scholar
  18. 18.
    Bossé, R., Sparrow, D., Rose, C. L., and Weiss, S. T., 1981, Longitudinal effect of age and smoking cessation on pulmonary function, Am. Rev. Respir. Dis. 123:378–381.PubMedGoogle Scholar
  19. 19.
    Buist, A. S., Nagy, J. M., and Sexton, G. J., 1979, The effect of smoking cessation on pulmonary function: A 30-month follow-up of two smoking cessation clinics, Am. Rev. Respir. Dis. 120:953–957.PubMedGoogle Scholar
  20. 20.
    Jones, N. L., Campbell, E. J. M., Edward, R. H. T., and Robertson, D. G., 1975, Clinical Exercise Testing, W. B. Saunders Co., Philadelphia.Google Scholar
  21. 21.
    Astrand, P-O., 1976, Quantification of exercise capability and evaluation of physical capacity in man, Prog. Cardiovasc, Dis. 19:51–67.Google Scholar
  22. 22.
    Astrand, P-O. and Rodahl, K., 1970, Textbook of Work Physiology, McGraw-Hill, New York.Google Scholar
  23. 23.
    Ouellet, Y., Poh, S. C., and Becklake, M. R., 1969, Circulatory factors limiting maximal aerobic exercise capacity, J. Appl. Physiol. 27:874–880.PubMedGoogle Scholar
  24. 24.
    Mahler, D. A. and Loke, J., 1981, Lung function after marathon running at warm and cold ambient temperatures, Am. Rev. Respir. Dis. 124:154–157.PubMedGoogle Scholar
  25. 25.
    Mahler, D. A. and Loke, J., 1981, Pulmonary dysfunction in ultramarathon runners, Yale J. Biol. Med. 54:243–248.PubMedGoogle Scholar
  26. 26.
    Loke, J., Mahler, D. A., and Virgulto, J., 1982, Respiratory muscle fatigue after marathon running, J. Appl. Physiol: Respirât. Environ. Exercise Physiol. 52:821–824.Google Scholar
  27. 27.
    Astrand, I., Astrand, P-O., Hallback, I., and Kilbom, A., 1973, Reduction in maximal oxygen uptake with age, J. Appl. Physiol. 35:649–654.PubMedGoogle Scholar
  28. 28.
    Dehn, M. M. and Bruce, R. A., 1972, Longitudinal variations in maximal oxygen intake with age and activity, J. Appl. Physiol. 33:805–807.PubMedGoogle Scholar
  29. 29.
    Robinson, S., Dill, D. B., Tzankoff, S. P., Wagner, J. A., and Robinson, R. D., 1975, Longitudinal studies of aging in 37 men, J. Appl. Physiol. 38:263–267.PubMedGoogle Scholar
  30. 30.
    Brandfonbrener, M., Landowne, M., and Shock, N. W., 1955, Changes in cardiac output with age, Circulation 12:557–566.PubMedGoogle Scholar
  31. 31.
    Becklake, M. R., Frank, H., Dagansis, G. R., Ostiguy, G. L., and Guzman, C. A., 1965, Influence of age and sex on exercise cardiac output, J. Appl. Physiol. 20:938–947.PubMedGoogle Scholar
  32. 32.
    Conway, J., Wheeler, R., and Sannerstedt, R., 1971, Sympathetic nervous activity during exercise in relation to age, Cardiovasc. Res. 5:577–581.PubMedGoogle Scholar
  33. 33.
    Julius, S., Antoon, A., Whitlock, L. S., and Conway, J., 1967, Influence of age on the hemodynamic response to exercise, Circulation 36:222–230.PubMedGoogle Scholar
  34. 34.
    Granath, A., Jonsson, B., and Strandell, T., 1964, Circulation in healthy old men studied by right heart catheterization at rest and during exercise in supine and sitting position, Acta Med. Scand. 176:425–446.PubMedGoogle Scholar
  35. 35.
    Lange-Anderson, K., Shephard, R. J., Denolin, H., Varnauskas, E., and Masi-roni, R., 1971, Fundamentals of Exercise Testing, World Health Organization, Geneva.Google Scholar
  36. 36.
    Port, S., Cobb, F. R., Coleman, E., and Jones, R. H., 1980, Effect of age on the response of the left ventricular ejection fraction to exercise, N. Engl. J. Med. 303:1133–1137.PubMedGoogle Scholar
  37. 37.
    Norris, A. H., Shock, N. W., and Yiengst, M. J., 1955, Age differences in ventilatory and gas exchange responses to graded exercise in males, J. Gerontol. 10:145–155.PubMedGoogle Scholar
  38. 38.
    Tzankoff, S. P., Robinson, S., Pyke, F. S., and Brown, C. A., 1972, Physiological adjustments to work in older men as affected by physical training, J. Appl. Physiol. 33:346–350.PubMedGoogle Scholar
  39. 39.
    Hanson, J. S., Tabakin, B. S., Levy, A. M., and Needle, W., 1968, Longterm physical training and cardiovascular dynamics in middle-aged men, Circulation 38:783–799.Google Scholar
  40. 40.
    Naughton, J. P. and Nagle, F., 1965, Peak oxygen intake during physical fitness program for middle-aged men, JAMA 191:899–901.PubMedGoogle Scholar
  41. 41.
    Barry, A. J., Daly, J. W., Pruett, E. D. R., Steinmetz, J. R., Page, H. F., Birkhead, N. D., and Rodahl, K., 1966, The effects of physical conditioning on older individuals. I. Work capacity, circulatory-respiratory functions, and work electrocardiogram, J. Gerontol. 21:182–191.PubMedGoogle Scholar
  42. 42.
    Holloszy, J. O., 1973, Biochemical adaptations to exercise: Aerobic metabolism, in: Exercise and Sport Sciences Reviews, Volume 1 (J. H. Wilmore, ed.) Academic Press, New York, pp. 46–102.Google Scholar
  43. 43.
    Meneely, G. R. (Chairman), 1962, Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema, Am. Rev. Respir. Dis. 85:762–768.Google Scholar
  44. 44.
    Deal, E. C., McFadden, E. R., Jr., Ingram, R. H., Jr., Strauss, R. H., and Jaeger, J. J., 1979, Role of respiratory heat exchange in production of exercise-induced asthma, J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 46:461–475.Google Scholar
  45. 45.
    Dosman, J. F., Bode, F., Urbanetti, J., Martin, R., and Macklem, P. T., 1975, The use of helium-oxygen mixture during maximum expiratory flow to demonstrate obstruction in small airways in smokers, J. Clin. Invest. 55:1090–1099.PubMedGoogle Scholar
  46. 46.
    Snider, G. L., Kory, R. C., and Lyons, H. A., 1967, Grading of pulmonary function impairment by means of pulmonary function tests, Chest 52:270–271.Google Scholar
  47. 47.
    Burrows, B. and Earle, R. H., 1969, Course and prognosis of chronic obstructive lung disease: A prospective study of 200 patients, N. Engl. J. Med. 280:397–404.PubMedGoogle Scholar
  48. 48.
    Snider, G. L. (Chairman), 1974, Criteria for the assessment of reversibility in airways obstruction, Chest 65:552–553.Google Scholar
  49. 49.
    Dull, W. L., Alexander, M. R., and Kasik, J. E., 1981, Isoproterenol challenge during placebo and oral theophylline therapy in chronic obstructive pulmonary disease, Am. Rev. Resp. Dis. 123:340–342.PubMedGoogle Scholar
  50. 50.
    McFadden, F. R. and Lyons, H. A., 1968, Arterial-blood gas tensions in asthma, N. Engl. J. Med. 278:1027–1032.PubMedGoogle Scholar
  51. 51.
    Matthay, R. A., Schwarz, M. I., Ellis, J. H., Jr., Steele, P. P., Siebert, P. E., Durrance, J. R., and Levin, D. C., 1981, Pulmonary artery hypertension in chronic obstructive pulmonary disease: Chest radiographic assessment, Invest. Radiol. 16:95–100.PubMedGoogle Scholar
  52. 52.
    Stubbing, D. G., Pengelly, L. D., Morse, J. L. C., and Jones, N. L, 1980, Pulmonary mechanics during exercise in subjects with chronic airflow obstruction, J. Appl. Physiol.: Respirât, Environ. Exercise Physiol. 49:511–515.Google Scholar
  53. 53.
    Jones, N. L., Jones, G., and Edwards, R. H. T., 1971, Exercise tolerance in chronic airway obstruction, Am. Rev. Respir. Dis. 103:477–491.PubMedGoogle Scholar
  54. 54.
    Minh, V., Lee, H. M., Dolan, D. G., Light, R. W., Bell, J., and Vasquez, P., 1979, Hypoxemia during exercise in patients with chronic obstructive pulmonary disease, Am. Rev. Respir. Dis. 120:787–794.PubMedGoogle Scholar
  55. 55.
    Grassino, A., Gross, D., Macklem, P. T., Roussos, C., and Zagelbaum, G., 1979, Inspiratory muscle fatigue as a factor limiting exercise, Bull. Europ. Physiopathol. Respir. 15:105–111.Google Scholar
  56. 56.
    Delgado, H. R., Braun, S. R., Skatrud, J. B., Reddan, W. G., and Pegelow, D. F., 1982, Chest wall and abdominal motion during exercise in patients with chronic obstructive pulmonary disease, Am. Rev. Respir. Dis. 126:200–205.PubMedGoogle Scholar
  57. 57.
    Pardy, R. L., Rivington, R. N., Despas, P. J., and Macklem, P. T., 1981, The effects of inspiratory muscle training on exercise performance in chronic airflow limitation, Am. Rev. Respir. Dis. 123:426–433.PubMedGoogle Scholar
  58. 58.
    Khaja, F. and Parker, J. O., 1971, Right and left ventricular performance in chronic obstructive lung disease, Am. Heart J. 82:319–327.PubMedGoogle Scholar
  59. 59.
    Minh, V-D., Lee, H. M, Vasquez, P., Shepard, J. W, and Bell, J. W, 1979, Relation of VO2max to cardiopulmonary function in patients with chronic obstructive lung disease, Bull. Europ. Physiopath. Respir. 15:359–375.Google Scholar
  60. 60.
    Matthay, R. A., Berger, H. J., Davies, R. A., Loke, J., Mahler, D. A., Gottschalk, A., and Zaret, B. L., 1980, Right and left ventricular exercise performance in chronic obstructive pulmonary disease: Radionuclide assessment, Ann. Int. Med. 93:234–239.PubMedGoogle Scholar
  61. 61.
    Mahler, D. A., Matthay, R. A., Berger, H. J., Brent, B. N., Loke, J., and Zaret, B. L., 1982, Right ventricular exercise performance in severe obstructive airway disease: Combined hemodynamic and radionuclide assessment, Am. Rev. Respir. Dis. 125:80 (Abstract).Google Scholar
  62. 62.
    Mahler, D. A., Weinberg, D. H., Wells, C. K., and Feinstein, A. R., 1982, Measurement of dyspnea: Description of two new indexes, interobserver agreement, and physiologic correlations, Am. Rev. Respir. Dis. 125:138 (Abstract).Google Scholar
  63. 63.
    Wolfe, J. D., Tashkin, D. P., Calvarese, B. and Simmons, M., 1978, Bronchodi-lator effects of terbutaline and aminophylline alone and in combination in asthmatic patients, N. Engl. J. Med. 298:363–367.PubMedGoogle Scholar
  64. 64.
    Eaton, M. L., Green, B. A., Church, T. R., McGowan, T., and Niewoehner, D. E., 1980, Efficacy of theophylline in “irreversible” airflow obstruction, Ann. Int. Med. 92:758–761.PubMedGoogle Scholar
  65. 65.
    Emirgil, C., Sobol, B. J., Norman, J., Muskowitz, E., Goyal, P., and Wadhwani, B., 1969, A study of the long-term effect of therapy in chronic obstructive pulmonary disease, Am. J. Med. 47:367–377.PubMedGoogle Scholar
  66. 66.
    Rossing, T. H., Fanta, C. H., Goldstein, D. H., Snapper, J. R., and McFadden, Jr., E. R., 1980, Emergency therapy of asthma: Comparison of acute effects of parental and inhaled sympathomimetics and infused aminophylline, Am. Rev. Respir. Dis. 122:365–371.PubMedGoogle Scholar
  67. 67.
    Shim, C. and Williams, M. H., Jr., 1980, Bronchial response to oral vs. aerosol metaproterenol in asthma, Ann. Int. Med. 93:428–431.PubMedGoogle Scholar
  68. 68.
    Dulfano, M. and Glass, P., 1973, Evaluation of a new beta2 adrenergic receptor stimulant, terbutaline, in bronchial asthma, II. Oral comparison with ephedrine, Curr. Ther. Res. 15:150–157.PubMedGoogle Scholar
  69. 69.
    Sly, R., Bodie, B., and Faciano, J., 1977, Comparison of subcutaneous terbutaline with epinephrine in the treatment of asthma in children, J. Allergy Clin. Immunol. 59:128–135.PubMedGoogle Scholar
  70. 70.
    Mitenko, P. A. and Ogilvie, R. I., 1973, Rational intravenous doses of theophylline, N. Engl. J. Med. 289:600–603, 1973.PubMedGoogle Scholar
  71. 71.
    Weinberger, M., Hendeles, L., and Ahrens, R., 1980, Pharmacologic management of reversible obstructive airways disease, Med. Clin. North Am. 65:579–613.Google Scholar
  72. 72.
    Aubier, M., Murciano, D., Viires, N., Lecocguic, Y., Fleury, B., and Pariente, R., 1982, Protective effects of aminophylline in diaphragmatic fatigue in acute respiratory failure, Am. Rev. Respir. Dis. 125:206 (Abstract).Google Scholar
  73. 73.
    Hendeles, L., Weinberger, M., and Bighley, L., 1977, Absolute bioavailability of oral theophylline, Amer. J. Hosp. Pharm. 34:525–527.Google Scholar
  74. 74.
    Jusko, W. J., Koup, J. R., Vance, J. W., Schentag, J. J., and Kuritzky, P., 1977, Intravenous theophylline therapy: Nomogram guidelines, Ann. Int. Med. 86:400–404.PubMedGoogle Scholar
  75. 75.
    Piafsky, K. M., Sitar, D. S., Rangno, R. E., and Ogilvie, R. I., 1977, Theophylline disposition in patients with hepatic cirrhosis, N. Engl. J. Med. 296:1495–1497.PubMedGoogle Scholar
  76. 76.
    Reitberg, D. P., Bernhard, H., and Schentag, J. J., 1981, Alteration of theophyl- line clearance and half-life by Cimetidine in normal volunteers, Ann. Int. Med. 95:582–585.PubMedGoogle Scholar
  77. 77.
    Arnaud, A., Vervloet, D., Dugue, P., Orehek, J., and Charpin, J., 1979, Treatment of acute asthma: Effect of intravenous corticosteroids and beta2 adrenergic agonists, Lung 156:43–48.PubMedGoogle Scholar
  78. 78.
    Albert, R. K., Martin, T. R., and Lewis, S. W., 1980, Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency, Ann. Int. Med. 92:753–758.PubMedGoogle Scholar
  79. 79.
    Ackerman, G. L. and Nolan, G. M., 1968, Adrenocortical responsiveness after alternate-day corticosteroid therapy, N. Engl. J. Med. 278:405–409.PubMedGoogle Scholar
  80. 80.
    Ballin, J. C., 1976, Evaluation of a new aerosolized steriod for asthma therapy, JAMA 236:2891–2893.PubMedGoogle Scholar
  81. 81.
    Byyny, R. L., 1976, Withdrawal from glucocorticoid therapy, N. Engl. J. Med. 295:30–32.PubMedGoogle Scholar
  82. 82.
    Hodson, M. E., Batten, J. C., Clarke, S. W., and Gregg, I., 1974, Beclomethasone dipropionate aerosol in asthma, Am. Rev. Respir. Dis. 110:403–408.PubMedGoogle Scholar
  83. 83.
    Williams, M. H., 1981, Beclomethasone dipropionate, Ann. Int. Med. 95:464–467.PubMedGoogle Scholar
  84. 84.
    A controlled trial by the British Thoracic and Tuberculosis Association, 1975, Inhaled corticosteroids compared with oral prednisone inpatients starting long-term corticosteroid therapy for asthma, Lancet ii:469–473.Google Scholar
  85. 85.
    Nocturnal Oxygen Therapy Trial Group, 1980, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease, Ann. Int. Med. 93:391–398.Google Scholar
  86. 86.
    Boysen, P. G., Block, A. J., Wynne, J. W., Hunt, L. A., and Flick, M. R., 1979, Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease, Chest 76:536–542.PubMedGoogle Scholar
  87. 87.
    Tirlapur, V. G. and Mir, M. A., 1982, Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease, N. Engl. J.Med. 306:125–130.PubMedGoogle Scholar
  88. 88.
    Report of the Medical Research Council Working Party, 1981, Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema, Lancet i:681–686.Google Scholar
  89. 89.
    Block, A. J., 1982, Dangerous sleep: Oxygen therapy for nocturnal hypoxemia. N. Engl. J. Med. 306:166–167.PubMedGoogle Scholar
  90. 90.
    Belman, M. J. and Wasserman, K., 1981, Exercise training and testing in patients with chronic obstructive pulmonary disease, Basics RD 10:1–6.Google Scholar
  91. 91.
    Grassino, A., Gross, D., Macklem, P. T., Roussos, Ch., and Zagelbaum, G., 1979, Inspiratory muscle fatigue as a factor limiting exercise. Bull. Eur. Physiopathol. Respir. 15:105–111.PubMedGoogle Scholar
  92. 92.
    Belman, M. J. and Mittman, C., 1980, Ventilatory muscle training improves exercise capacity in chronic obstructive pulmonary disease patients, Am. Rev. Respir. Dis. 121:273–280.PubMedGoogle Scholar
  93. 93.
    Franciosa, J. A. and Fischer, H. A., 1981, Right ventricular unloading: Lessons from the left, Ann. Int. Med. 95:647–648.PubMedGoogle Scholar
  94. 94.
    Rubin, L. J. and Peter, R. H., 1981, Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale, Am. J. Cardiol. 47:116–122.PubMedGoogle Scholar
  95. 95.
    Simonneau, G., Eacourrou, P., Duroux, P., and Lockhart, A., 1981, Inhibition of hypoxic pulmonary vasoconstriction by nifedipine, N. Engl. J. Med. 304:1582–1585.PubMedGoogle Scholar
  96. 96.
    Muramoto, A., Caldwell, J., Lakshinarayan, S., Albert, R. K., and Butler, J., 1981, Nifedipine reduces pulmonary artery pressure at a comparable cardiac output in patients with chronic obstructive pulmonary disease, Circulation 64(Suppl. IV):179 (Abstract).Google Scholar
  97. 97.
    Matthay, R. A. and Berger, H. J., 1981, Cardiovascular performance in chronic obstructive pulmonary disease, Med. Clin. North Am. 65:489–524.PubMedGoogle Scholar
  98. 98.
    Abraham, A. S., Cole, R. B., and Bishop, J. M., 1968, Reversal of pulmonary hypertension by prolonged oxygen administration in patients with chronic bronchitis, Circ. Res. 23:147–157.PubMedGoogle Scholar
  99. 99.
    Olvey, S. K., Reduto, L. A., Stevens, P. M., Deaton, W. J., and Miller, R. R., 1980, First-pass radionuclide assessment of right and left ventricular ejection fraction in chronic pulmonary disease: Effect of oxygen upon exercise response, Chest 78:4–9.PubMedGoogle Scholar
  100. 100.
    Gertz, I., Hedensteirna, G., and Wester, P. O., 1979, Improvement in pulmonary function with diuretic therapy in the hypervolemic and polycytemic patient with chronic obstructive pulmonary disease, Chest 75:146–151.PubMedGoogle Scholar
  101. 101.
    Green, L. H. and Smith, T. W., 1977, The use of digitalis in patients with pulmonary disease, Ann. Int. Med. 87:459–465.PubMedGoogle Scholar
  102. 102.
    Mathur, P. N., Powles, A. C. P., Pugsley, S. O., McEwan, M. P., and Campbell, E. J. M., 1981, Effect of digoxin on right ventricular function in severe chronic airflow obstruction, Ann. Int. Med. 95:283–288.PubMedGoogle Scholar
  103. 103.
    Center for Disease Control, 1980, Annual Summary 1979, Morbid. Mortal. Weekly Rep. 28:54–55.Google Scholar
  104. 104.
    Siegel, J. S., 1982,Some demographic aspects of aging in the United States, in: The Epidemiology of Aging (A. M. Ostfeld and D. C. Gibson, eds.), DHEW, Publication No. (NIH) 77–711, Bethesda, Md.Google Scholar
  105. 105.
    Sullivan, R. J., Dowdle, W. R., Marine, W. M., 1972, Adult pneumonia in a general hospital: Etiology and host risk factors, Arch. Int. Med. 129:935–942.Google Scholar
  106. 106.
    Phair, J. P., Kauffman, C. A., Bjornson, A., 1978, Host defenses in the aged: Evaluation of components of the inflammatory and immune responses, J. Infect. Dis. 138:67–73.PubMedGoogle Scholar
  107. 107.
    Buckley, C. E. and Dorsey, F. C., 1970, The effect of aging on human serum immunoglobulin concentrations, J. Immunol. 105:964–972.PubMedGoogle Scholar
  108. 108.
    Weksler, M. E. and Hutteroth, T. H., 1974, Impaired lymphocyte function in aged humans, J. Clin. Invest. 53:99–104.PubMedGoogle Scholar
  109. 109.
    Elright, J. R. and Rytel, M. W., 1980, Bacterial pneumonia in the elderly, J. Am. Geriatr. Soc. 28:220–223.Google Scholar
  110. 110.
    Garb, J. L., Brown, R. B., Garb, J. R., and Tuthill, R. W., 1978, Differences in etiology of pneumonias in nursing home and community patients, JAMA 240:2169–2172.PubMedGoogle Scholar
  111. 111.
    Valenti, W. M., Trudell, R. G., and Bentley, D. W., 1978, Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged, N. Engl. J. Med. 298:1108–1111.PubMedGoogle Scholar
  112. 112.
    Stamm, W. E., 1979, Gram-negative pneumonias: Diagnosis and management, Drug Ther. 9:69–80.Google Scholar
  113. 113.
    Wanner, A., 1979, The role of mucociliary dysfunction in bronchial asthma, Am. J. Med. 67:477–485.PubMedGoogle Scholar
  114. 114.
    Frame, P. T., 1982, Acute infectious pneumonia in the adult, Basics RD 10:1–8.Google Scholar
  115. 115.
    Robbins, S. L. and Cotran, R. S., 1979, Pneumonia, in: Pathologic Basis of Disease, W. B. Saunders Co., Philadelphia.Google Scholar
  116. 116.
    Oswald, N. C., Simon, G., and Shooter, R. A., 1961, Pneumonia in hospital practice, Br. J. Dis. Chest 55:109–118.PubMedGoogle Scholar
  117. 117.
    Bartlett, J. G. and Gorbach, S. L., 1975, The triple threat of aspiration pneumonia, Chest 68:560–566.PubMedGoogle Scholar
  118. 118.
    Mendelson, C. L., 1946, The aspiration of stomach contents into the lungs during obstetric anesthesia, Am. J. Obstet, Gynecol. 52:191–205.Google Scholar
  119. 119.
    Greenfield, L. J., Singleton, R. P., McCaffree, D. R., 1969, Pulmonary effects of experimental graded aspiration of hydrochloric acid, Ann. Surg. 170:74–86.PubMedGoogle Scholar
  120. 120.
    Center for Disease Control, 1978, Legionnaires’ disease: Diagnosis and management, Ann. Int. Med. 88:363–365.Google Scholar
  121. 121.
    Kirby, B. D., Snyder, K. M., Meyer, R. D., and Finegold, S. M., 1978, Legionnaires’ disease: Clinical features of 24 cases, Ann. Int. Med. 89:297–309.PubMedGoogle Scholar
  122. 122.
    Douglas, R. G., Jr., 1976, Influenza: The disease and its complications, Hosp. Practice (Dec):43–50.Google Scholar
  123. 123.
    Weinstein, L., 1980, The “new” pneumonias: The doctor’s dilemma, Ann. Int. Med. 92:559–561.PubMedGoogle Scholar
  124. 124.
    Edelstein, P. H., Meyer, R. D., and Finegold, S. M., 1980, Laboratory diagnosis of Legionnaires’ disease, Am. Rev. Respir. Dis. 121:317–327.PubMedGoogle Scholar
  125. 125.
    Hébert, G. A., Thomason, B. M., Harris, P. P., Hicklin, M. D., and McKinney, R. M., 1980, “Pittsburgh Pneumonia Agent”: A bacterium phenotypically similar to Legionella pneumophila and identical to the TATLOCK bacterium, Ann. Int. Med. 92:53–54.PubMedGoogle Scholar
  126. 125a.
    Roberts, R. B., 1982, Antimicrobial therapy, in: Cecil Textbook of Medicine (J. B. Wyngaarden and L. H. Smith, Jr. eds.), W. B. Saunders, Philadelphia, pp. 71–83.Google Scholar
  127. 125b.
    Kirby, W. M. M., Chemotherapy of infection, in: Harrison’s Principles of InternalMedicine (K. J. Isselbacher, R. D. Adams, E. Breunwald, R. G. Petersdorf, and J. D. Wilson, eds.), McGraw-Hill, New York, pp. 573–586.Google Scholar
  128. 126.
    Bartlett, J. G., 1980, Aspiration pneumonia, Clin. Notes Respir. Dis. 18:(4):3–8.PubMedGoogle Scholar
  129. 127.
    Position paper of the ATS ad hoc advisory committee on influenza, 1981, Prevention of influenza and pneumonia, Am. Thoracic Soc. News, p. 41.Google Scholar
  130. 128.
    Broome, C. V. and Facklam, R. R., 1981, Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States, Rev. Infect. Dis. 3:277–280.PubMedGoogle Scholar
  131. 129.
    Recommendation of the Immunization Practices Advisory Committee, 1981, Pneumococcal polysaccharide vaccine, Morbid. Mortal. Weekly Rep. 30:410–419.Google Scholar
  132. 130.
    Recommendation of the Public Health Service Immunization Practices Advisory Committee, 1981, Influenza vaccine 1981–82, Morbid. Mortal. Weekly Rep. 30:279–288.Google Scholar

Copyright information

© Plenum Publishing Corporation 1983

Authors and Affiliations

  • Donald A. Mahler
    • 1
  1. 1.Pulmonary Function Laboratory, and Pulmonary Section, Department of MedicineDartmouth Medical SchoolHanoverUSA

Personalised recommendations